Neat Digest  ·  Archive  ·  Open in app ↗

AbbVie gains EU approval of atogepant for acute migraine

Score 4.9/10 · Standard · Health · 1 sources · June 2, 2026
AbbVie gains EU approval of atogepant for acute migraine

Summary: AbbVie announced that the European Commission has approved atogepant...

Sources on this story

Reported by 1 sources, including:

  • Seeking Alpha